133 related articles for article (PubMed ID: 35023152)
1. Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processes.
Feroz H; Chennamsetty N; Byers S; Holstein M; Li ZJ; Ghose S
Biotechnol Bioeng; 2022 Apr; 119(4):1091-1104. PubMed ID: 35023152
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of the 2019 Viral Clearance Symposium, Session 5: Viral Inactivation.
Ma J
PDA J Pharm Sci Technol; 2022; 76(4):339-348. PubMed ID: 34911831
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a Triton X-100 replacement for virus inactivation.
Luo W; Hickman D; Keykhosravani M; Wilson J; Fink J; Huang L; Chen D; O'Donnell S
Biotechnol Prog; 2020 Nov; 36(6):e3036. PubMed ID: 32533632
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of "Nereid," a new phenol-free detergent to replace Triton X-100 in virus inactivation.
Farcet JB; Kindermann J; Karbiener M; Scheinecker R; Kostner O; Kreil TR
J Med Virol; 2021 Jun; 93(6):3880-3889. PubMed ID: 33274764
[TBL] [Abstract][Full Text] [Related]
6. Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC.
Farcet JB; Karbiener M; Zelger L; Kindermann J; Kreil TR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175626
[TBL] [Abstract][Full Text] [Related]
7. Identification of compendial nonionic detergents for the replacement of Triton X-100 in bioprocessing.
Hunter AK; Rezvani K; Aspelund MT; Xi G; Gadre D; Linke T; Cai K; Mulagapati SHR; Witkos T
Biotechnol Prog; 2022 Mar; 38(2):e3235. PubMed ID: 35043591
[TBL] [Abstract][Full Text] [Related]
8. Study of detergent-mediated liberation of hepatitis B virus-like particles from S. cerevisiae homogenate: identifying a framework for the design of future-generation lipoprotein vaccine processes.
Kee GS; Pujar NS; Titchener-Hooker NJ
Biotechnol Prog; 2008; 24(3):623-31. PubMed ID: 18429641
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of dual-detergent strategy using Triton X-100 in membrane protein purification.
Das A; Bysack A; Raghuraman H
Biochem Biophys Res Commun; 2021 Nov; 578():122-128. PubMed ID: 34560581
[TBL] [Abstract][Full Text] [Related]
10. Insights into virus inactivation by polysorbate 80 in the absence of solvent.
Chen D; Luo W; Hoffman J; Huang L; Sandefur S; Hall T; Murphy M; O'Donnell S
Biotechnol Prog; 2020 May; 36(3):e2953. PubMed ID: 31846227
[TBL] [Abstract][Full Text] [Related]
11. On-column virus inactivation by solvent/detergent treatment for a recombinant biological product.
Polasek D; Flicker A; Fiedler C; Farcet MR; Purtscher M; Kreil TR
Biologicals; 2023 Aug; 83():101693. PubMed ID: 37516085
[TBL] [Abstract][Full Text] [Related]
12. Supported Lipid Bilayer Platform for Characterizing the Membrane-Disruptive Behaviors of Triton X-100 and Potential Detergent Replacements.
Gooran N; Yoon BK; Jackman JA
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055053
[TBL] [Abstract][Full Text] [Related]
13. Enveloped virus inactivation using neutral arginine solutions and applications in therapeutic protein purification processes.
McCue JT; Selvitelli K; Cecchini D; Brown R
Biotechnol Prog; 2014; 30(1):108-12. PubMed ID: 24124172
[TBL] [Abstract][Full Text] [Related]
14. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
15. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
16. Ebola Virus Inactivation by Detergents Is Annulled in Serum.
van Kampen JJA; Tintu A; Russcher H; Fraaij PLA; Reusken CBEM; Rijken M; van Hellemond JJ; van Genderen PJJ; Koelewijn R; de Jong MD; Haddock E; Fischer RJ; Munster VJ; Koopmans MPG
J Infect Dis; 2017 Oct; 216(7):859-866. PubMed ID: 28961947
[TBL] [Abstract][Full Text] [Related]
17. Single-use technology for solvent/detergent virus inactivation of industrial plasma products.
Hsieh YT; Mullin L; Greenhalgh P; Cunningham M; Goodrich E; Shea J; Youssef E; Burnouf T
Transfusion; 2016 Jun; 56(6):1384-93. PubMed ID: 27125447
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembly Behavior and Application of Terphenyl-Cored Trimaltosides for Membrane-Protein Studies: Impact of Detergent Hydrophobic Group Geometry on Protein Stability.
Ehsan M; Du Y; Mortensen JS; Hariharan P; Qu Q; Ghani L; Das M; Grethen A; Byrne B; Skiniotis G; Keller S; Loland CJ; Guan L; Kobilka BK; Chae PS
Chemistry; 2019 Sep; 25(49):11545-11554. PubMed ID: 31243822
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nonionic detergents with the specific sites of lysozyme amyloidogenic region - inhibition of amyloid fibrillization.
Siposova K; Kozar T; Musatov A
Colloids Surf B Biointerfaces; 2017 Feb; 150():445-455. PubMed ID: 27842932
[TBL] [Abstract][Full Text] [Related]
20. Truly continuous low pH viral inactivation for biopharmaceutical process integration.
Martins DL; Sencar J; Hammerschmidt N; Flicker A; Kindermann J; Kreil TR; Jungbauer A
Biotechnol Bioeng; 2020 May; 117(5):1406-1417. PubMed ID: 32017010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
